Update: evaluation of human T-lymphotropic virus. Type III/lymphadenopathy-associated virus infection in health-care personnel--United States. Centers for Disease Control. - Suppr | 超能文献

Update: evaluation of human T-lymphotropic virus. Type III/lymphadenopathy-associated virus infection in health-care personnel--United States. Centers for Disease Control.

出版信息

Conn Med. 1985 Nov;49(11):772.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Update: evaluation of human T-lymphotropic virus. Type III/lymphadenopathy-associated virus infection in health-care personnel--United States. Centers for Disease Control.

Conn Med. 1985 Nov;49(11):772.

2

Update: evaluation of human T-lymphotropic virus type III/lymphadenopathy-associated virus infection in health-care personnel--United States.

MMWR Morb Mortal Wkly Rep. 1985 Sep 27;34(38):575-8.

3

Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections. Centers for Disease Control, U.S. Department of Health and Human Services.

Ann Intern Med. 1986 Aug;105(2):234-7.

4

Revision of the case definition of acquired immunodeficiency syndrome for national reporting--United States. Centers for Disease Control, Department of Health and Human Services.

Ann Intern Med. 1985 Sep;103(3):402-3.

5

Immunization of children infected with human T-lymphotropic virus type III/lymphadenopathy-associated virus. Recommendations of the Immunization Practices Advisory Committee. Centers for Disease Control, Department of Health and Human Services.

Ann Intern Med. 1987 Jan;106(1):75-8.

6

Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections.

MMWR Morb Mortal Wkly Rep. 1986 May 23;35(20):334-9.

7

[Prevalence of antibodies against the lymphadenopathy-associated virus/human T-cell lymphotropic virus type III (LAV/HTLV) in a population of homosexuals in Mexico].

Salud Publica Mex. 1986 Mar-Apr;28(2):180-5.

8

Additional recommendations to reduce sexual and drug abuse-related transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus.

MMWR Morb Mortal Wkly Rep. 1986 Mar 14;35(10):152-5.

9

Immunization of children infected with human T-lymphotropic virus type III/ lymphadenopathy-associated virus.

MMWR Morb Mortal Wkly Rep. 1986 Sep 26;35(38):595-8,603-6.

10

Transfusion-associated human T-lymphotropic virus type III/lymphadenopathy-associated virus infection from a seronegative donor--Colorado.

MMWR Morb Mortal Wkly Rep. 1986 Jun 20;35(24):389-91.